The nation of Zimbabwe has declined a significant US healthcare agreement valued at 367 million US dollars (£272m) spanning five years over the United States' request for sensitive information.
This move became public after a government memo from December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesman has since explained that the US was seeking health data for research and profit but was unwilling to guarantee the benefits from any future treatments.
"We must now begin the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for further negotiations to find a deal agreeable to all parties so the nation's critical HIV treatment initiative can be sustained.
Wider Implications
This development follows a comparable situation in Kenya, where a court halted a similar health funding agreement following legal challenges were filed about the safety of Kenyans' health data.
After returning to office recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government deals to boost openness and accountability.
According to reports, Sixteen African countries have so far agreed to similar health pacts, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to surrender its biological resources and data for a long time, without any equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that provided information," he stated.
"Put simply, our country would supply the basic resources for medical research with no assurance that the resulting innovations would be accessible to our citizens if a future disease outbreak arise."
National Interest and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its push of bilateral deals were disrupting frameworks previously established through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.
"This system is intended to guarantee that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome continued dialogue with our American counterparts on how future collaboration could be designed in a way that respects the sovereignty and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but suggested that talks should continue since a large portion of the country's Aids initiatives depended on foreign aid.
"In cases where technical issues arise, including those involving information security or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," it said.
The situation underscores the continuing tensions between accepting crucial international aid and protecting local interests in an ever more data-driven world.